GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,869.50p
   
  • Change Today:
      16.00p
  • 52 Week High: 2,208.00
  • 52 Week Low: 1,442.50
  • Currency: UK Pounds
  • Shares Issued: 4,045.41m
  • Volume: 1,770,737
  • Market Cap: £75,629m
  • RiskGrade: 129
  • Beta: 0.00

Latest ShareCast News

GSK advances mRNA flu shot after Phase II success

By Iain Gilbert

Date: Tuesday 01 Sep 2026

(Sharecast News) - Drugmaker GSK said on Tuesday that it will move its mRNA seasonal flu vaccine candidate into Phase III after reporting positive Phase II results at the OPTIONS XIII influenza conference.

GSK ShareCast News

GSK notches major regulatory milestones in Japan... 24-Aug-2026 ShareCast
GSK launches £2bn cost savings drive, confirms n... 28-Jul-2026 ShareCast
GSK secures EMA review for single‑dose Bex... 20-Jul-2026 ShareCast
GSK shares fall as cough drug development axed 17-Jul-2026 ShareCast
GSK rectal cancer drug shows positive result in ... 13-Jul-2026 ShareCast

GSK Regulatory News

mRNA flu vaccine candidate to advance to phase III 01-Sep-2026 07:00 RNS
Director/PDMR Shareholding 26-Aug-2026 15:30 RNS
Director/PDMR Shareholding 24-Aug-2026 15:30 RNS
First global approval for Hibsago in Japan 24-Aug-2026 07:02 RNS
US FDA to review Jemperli for rectal cancer 24-Aug-2026 07:00 RNS

GSK Newspaper Links

GSK invests £400m to relocate research headquart... 28-Jul-2026 Times
GSK to buy US cancer treatment firm Nuvalent for... 09-Jun-2026 Guardian
GSK signs £45m deal with UCL offshoot for liver ... 08-Jun-2026 Times
Strong vaccine sales deliver an early boost for ... 29-Apr-2026 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,869.50p
Change Today 16.00p
% Change 0.86 %
52 Week High 2,208.00
52 Week Low 1,442.50
Volume 1,770,737
Shares Issued 4,045.41m
Market Cap £75,629m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 13-Aug-26 14-May-26
Paid 08-Oct-26 09-Jul-26
Amount 17.00p 17.00p

Trades for 01-Sep-2026

Time Volume / Share Price
13:28 0 @ 1,870.00p
13:28 1 @ 1,870.00p
13:28 0 @ 1,870.00p
13:28 88 @ 1,869.50p
13:27 175 @ 1,869.00p

GSK Key Personnel

CEO Luke Miels

Top of Page